XML 41 R25.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Share Repurchase Program
On February 15, 2024, the Company announced that the Board of Directors approved the repurchase of an additional $150 million in shares of common stock over a three-year period. This authorization was an increase to the previous $150 million repurchase program approved in August 2021 and the previous $100 million repurchase programs approved in November 2018, February 2017, and February 2016. The repurchase program is set to expire in February 2027. Stock repurchases under this program may be made in the open market or in private transactions at times and in amounts determined by the Company. As of December 31, 2024, $124.2 million remained available under the program.
Common and Preferred Stock
The Board of Directors has the authority to issue common and unclassed preferred stock of up to 200 million shares and 25 million shares, respectively, with par value of $0.01 per share, as well as to fix dividends, voting and conversion rights, redemption provisions, liquidation preferences, and other rights and restrictions.
Accumulated Other Comprehensive Income (Loss) (“AOCI”)
Changes in AOCI by component, net of tax, for the years ended December 31, 2024, 2023, and 2022 are summarized as follows (in thousands):
Foreign Currency TranslationDerivative InstrumentsTotal
Balances at December 31, 2021$(1,989)$2,848 $859 
Net unrealized gains (losses) arising during the period(a)
198 1,727 1,925 
Less: Net realized gains (losses) reclassified to net loss(b)
— 3,666 3,666 
Net change during the period198 (1,939)(1,741)
Balances at December 31, 2022(1,791)909 (882)
Net unrealized gains (losses) arising during the period(c)
975 (3,063)(2,088)
Less: Net realized gains (losses) reclassified to net income(d)
— (2,542)(2,542)
Net change during the period975 (521)454 
Balances at December 31, 2023(816)388 (428)
Net unrealized gains (losses) arising during the period(e)
(2,183)(1,328)(3,511)
Less: Net realized gains (losses) reclassified to net income(f)
— (710)(710)
Net change during the period(2,183)(618)(2,801)
Balances at December 31, 2024$(2,999)$(230)$(3,229)
—————————
(a) Derivative instruments net of $0.6 million of tax expense for the year ended December 31, 2022.
(b) Derivative instruments net of $1.2 million of tax expense for the year ended December 31, 2022.
(c) Derivative instruments net of $1.0 million of tax benefit for the year ended December 31, 2023.
(d) Derivative instruments net of $0.8 million of tax benefit for the year ended December 31, 2023.
(e) Derivative instruments net of $0.4 million of tax benefit for the year ended December 31, 2024.
(f) Derivative instruments net of $0.2 million of tax benefit for the year ended December 31, 2024.